Related Experiment Video
Updated: Oct 17, 2025

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven
Jolien De Wyn1, Mark W Zimmerman2, Nina Weichert-Leahey2
1Department for Biomolecular Medicine, Ghent University, Medical Research Building (MRB1), Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
Abstract:
Roughly half of all high-risk neuroblastoma patients present with MYCN amplification. The molecular consequences of MYCN overexpression in this aggressive pediatric tumor have been studied for decades, but thus far, our understanding of the early initiating steps of MYCN-driven tumor formation is still enigmatic. We performed a detailed transcriptome landscaping during murine TH-MYCN-driven neuroblastoma tumor formation at different time points. The neuroblastoma dependency factor MEIS2, together with ASCL1, was identified as a candidate tumor-initiating factor and shown to be a novel core regulatory circuit member in adrenergic neuroblastomas. Of further interest, we found a KEOPS complex member (gm6890), implicated in homologous double-strand break repair and telomere maintenance, to be strongly upregulated during tumor formation, as well as the checkpoint adaptor Claspin (CLSPN) and three chromosome 17q loci CBX2, GJC1 and LIMD2. Finally, cross-species master regulator analysis identified FOXM1, together with additional hubs controlling transcriptome profiles of MYCN-driven neuroblastoma. In conclusion, time-resolved transcriptome analysis of early hyperplastic lesions and full-blown MYCN-driven neuroblastomas yielded novel components implicated in both tumor initiation and maintenance, providing putative novel drug targets for MYCN-driven neuroblastoma.
Insights
Researchers identified key factors like MEIS2 and ASCL1 driving neuroblastoma formation in MYCN-amplified tumors. This study reveals novel therapeutic targets for this aggressive pediatric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MYCN amplification is present in about half of high-risk neuroblastoma patients.
- The early steps of MYCN-driven neuroblastoma initiation remain poorly understood.
- Understanding these early events is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the molecular landscape of early neuroblastoma development in a MYCN-driven model.
- To identify novel factors involved in tumor initiation and maintenance.
- To discover potential therapeutic targets for MYCN-driven neuroblastoma.
Main Methods:
- Performed time-resolved transcriptome analysis in a murine TH-MYCN neuroblastoma model.
- Utilized bioinformatics to identify candidate tumor-initiating factors and regulatory circuits.
- Conducted cross-species master regulator analysis to identify key transcriptional hubs.
Main Results:
- Identified MEIS2 and ASCL1 as potential tumor-initiating factors in adrenergic neuroblastomas.
- Found upregulation of KEOPS complex member (gm6890), Claspin (CLSPN), and chromosome 17q loci (CBX2, GJC1, LIMD2) during tumor formation.
- FOXM1 identified as a master regulator controlling transcriptome profiles in MYCN-driven neuroblastoma.
Conclusions:
- Time-resolved transcriptome analysis revealed novel components in early neuroblastoma lesions and established tumors.
- These findings implicate new factors in both the initiation and maintenance of MYCN-driven neuroblastoma.
- Identified putative novel drug targets for therapeutic intervention in MYCN-driven neuroblastoma.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic...
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Abnormal Proliferation
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...